Forge Therapeutics

Forge Therapeutics Overview

Founded 2015
Founded
Status Private
Latest Deal Type Grant
Latest Deal Amount $11.1M
Latest Deal Amount
Investors 13

Forge Therapeutics General Information

Description

Developer of an innovative drug discovery platform designed to offer novel antibiotics to treat multi-drug resistant bacteria. The company's platform develops small molecule inhibitors targeting metalloenzymes using gram-negative bacteria, enabling healthcare professionals to access various biochemical processes and biological catalysis.to treat diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 10578 Science Center Drive
  • Suite 205
  • San Diego, CA 92121
  • United States

Forge Therapeutics Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Forge Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 03-Jan-2019 $11.1M 000.00 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 01-Dec-2017 000.00 000.00 Completed Pre-Clinical Trials
2. Grant 26-Jul-2016 $8.8M Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2015 Completed Pre-Clinical Trials

Forge Therapeutics Cap Table

To view Forge Therapeutics‘s complete cap table, request access >>
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000

Forge Therapeutics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
SelectX Pharmaceuticals Venture Capital-Backed Boston, MA 00 000.00 00000000000 000.00
00000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
000000000 Venture Capital-Backed Basel, Switzerland 00 000.00 0000000000 000.00
000000 00000000000 Formerly VC-backed San Jose, CA 00 000.00 000000000 000.00
000000 00000000000 Corporation PA 000 000.00 00000000 000.00

Forge Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Zachary Zimmerman Ph.D Co-Founder, Chief Executive Officer & Board Memberg
Esther van den Boom Chief Financial Officer
David Puerta Ph.D Co-Founder, Chief Operating Officer & Vice President of Discovery
Seth Cohen Ph.D Scientific Co-Founder & Advisor

1 Former Executive

Forge Therapeutics Board Members (7)

To view Forge Therapeutics‘s full board member team, request access >>
Name Representing Role Since
Brian Dorsey Self Board Member 000 0000
Jeffrey Moore Ph.D MP Healthcare Venture Management Board Member 000 0000
John Schmid Self Board Member 000 0000
Jonathan Kabakoff Alexandria Venture Investments Board Observer 000 0000
Mario Polywka Ph.D Evotec Board Member 000 0000

Forge Therapeutics Investors (13)

To view Forge Therapeutics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Evotec Corporation Minority 000 0000 000000 0
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
MagnaSci Ventures Venture Capital Minority 000 0000 000000 0
MP Healthcare Venture Management Corporate Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial